Home›Stock Screener›Reliance Chemotex›Financial Statements

Reliance Chemotex Complete Financial Statements

12 Years of Data
2026 - 2015

In FY2026, Reliance Chemotex (RELCHEMQ) reported revenue ₹362 Cr, net profit ₹5 Cr and EPS ₹6.97, with a net profit margin of 1.4% and ROE of 3.5%. Full financial statements from FY2015 to FY2026 (12 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. For live price, earnings ratios and company overview, see Reliance Chemotex stock price NSE.

Complete Financial Data Export

Profitability Ratios

Net Profit Margin 1.38% 2026 data
EBITDA Margin 11.33% 2026 data
Operating Margin 11.00% 2026 data
Return on Assets 0.98% 2026 data
Return on Equity 3.50% 2026 data

Balance Sheet Ratios

Current Ratio 0.92 2026 data
Equity Ratio 27.93% 2026 data
Asset Turnover 0.71 2026 data

RELCHEMQ Revenue, Net Profit & EBITDA — Year-on-Year Growth

RELCHEMQ YoY (March 2025 vs March 2026) — revenue -1.9%, net profit +25.0%, EBITDA -2.4%, expenses -1.5%. Analyse RELCHEMQ shareholding pattern to track promoter, FII and institutional holdings.

Revenue Growth
-1.9%
Year-over-Year
Net Profit Growth
+25.0%
Year-over-Year
EBITDA Growth
-2.4%
Year-over-Year
Expense Growth
-1.5%
Year-over-Year
Assets Growth
+8.0%
Year-over-Year
Equity Growth
+4.4%
Year-over-Year
Operating Cash Flow Growth
-38.9%
Year-over-Year
Investing Cash Flow Growth
+140.2%
Year-over-Year
Financing Cash Flow Growth
-171.7%
Year-over-Year

RELCHEMQ Income Statement — Revenue, EBITDA & Net Profit

Reliance Chemotex revenue ₹362 Cr, EBITDA ₹41 Cr, net profit ₹5 Cr, EPS ₹6.97 (2026) — net profit margin 1.4%. Also explore RELCHEMQ stock price history to track price trends across different timeframes.

Periods ₹ Crores
Particulars March 2026 March 2025 March 2024 March 2023 March 2022 March 2021 March 2020 March 2019 March 2018 March 2017 March 2016 March 2015
Revenue 362 369 372 371 368 260 301 326 286 295 260 251
Expenses 321 326 336 331 320 233 271 298 265 269 238 224
EBITDA 41 42 35 40 48 28 29 28 21 26 21 27
Operating Profit Margin % 11.00% 9.00% 8.00% 9.00% 11.00% 9.00% 9.00% 8.00% 7.00% 8.00% 7.00% 5.00%
Depreciation 15 15 10 10 9 8 7 7 7 7 7 6
Interest 25 24 20 14 12 10 11 13 12 14 13 13
Profit Before Tax 5 4 6 17 27 10 11 8 1 5 2 9
Tax 0 0 2 4 9 3 1 4 -2 -2 -1 3
Net Profit 5 4 3 12 18 7 9 4 3 7 3 7
Earnings Per Share (₹) 6.97 5.36 4.26 16.46 24.04 9.19 14.68 10.28 6.53 16.30 -0.62 10.11

RELCHEMQ Balance Sheet — Assets, Liabilities & Shareholders' Equity

RELCHEMQ total assets ₹512 Cr, total equity ₹143 Cr, total liabilities ₹ Cr (2026) — ROE 3.5%.

Years Annual Data ₹ Crores
Particulars 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
ASSETS
Total Assets 512 474 481 397 333 263 227 218 228 227 201 191
Current Assets 183 153 156 146 131 106 76 75 80 72 90 78
Fixed Assets 299 313 318 196 181 148 136 140 145 152 109 107
Capital Work in Progress 0 0 1 39 10 1 6 0 0 0 1 2
Investments 100 0 0 0 0 0 0 0 0 0 0 0
Other Assets 0 162 163 162 142 113 85 79 82 76 91 83
LIABILITIES
Total Liabilities
Current Liabilities 199 169 184 100 78 56 49 71 65 77 58 72
Non-Current Liabilities
SHAREHOLDERS' EQUITY
Total Equity 143 137 134 132 121 104 98 67 70 68 59 59
Share Capital 8 8 8 8 8 8 8 4 4 4 27 27
Reserves & Surplus 135 130 126 124 114 97 91 63 66 64 32 32

RELCHEMQ Cash Flow Statement — Operating, Investing & Financing

Reliance Chemotex operating cash flow ₹11 Cr, investing ₹33 Cr, financing ₹-43 Cr, net cash flow ₹0 Cr (2025).

Periods ₹ Crores
Particulars March 2025 March 2024 March 2023 March 2022 March 2021 March 2020 March 2019 March 2018 March 2017 March 2016 March 2015
Operating Activities 11 18 0 59 27 22 26 11 32 12 0
Investing Activities 33 -82 -51 -74 -43 -8 0 0 -2 -6 -27
Financing Activities -43 60 55 14 15 -13 -26 -11 -30 -6 28
Net Cash Flow 0 -4 4 0 0 1 0 -1 0 0 1